1-3 of 3
Amarnath Natarajan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Spirocyclic Dimer (SpiD3) Resensitizes CLL Cells to Venetoclax

Alexandria P Eiken, Sydney A Skupa, Neecole Brown, Audrey L Smith, Sarbjit Singh, Sandeep Rana, Amarnath Natarajan, Dalia ElGamal
Journal: Blood
Blood (2022) 140 (Supplement 1): 8872–8873.
https://doi.org/10.1182/blood-2022-170983
Published: 2022
Journal Articles

A Novel Spirocyclic Dimer (36-286) Targeting the NF-Kappa B Pathway Displays Potent Anti-Tumor Properties in Chronic Lymphocytic Leukemia

Alexandria P Eiken, Audrey L Smith, Sarbjit Singh, Sandeep Rana, Sunandini Sharma, Amarnath Natarajan, Dalia ElGamal
Journal: Blood
Blood (2021) 138 (Supplement 1): 1186.
https://doi.org/10.1182/blood-2021-152632
Published: 2021
Journal Articles

Novel Treatment for Therapy-Resistant Mantle Cell Lymphoma Targeting NF-κB and mTOR Signaling Pathways in Vitro and in Vivo

Nagendra K Chaturvedi, PhD, Rajkumar Rajule, PhD, Shukla Ashima, BS, Prakash Radhakrishnan, PhD, Amarnath Natarajan, PhD, Julie M Vose, MD, MBA, Shantaram S Joshi, PhD
Journal: Blood
Blood (2012) 120 (21): 63.
https://doi.org/10.1182/blood.V120.21.63.63
Published: 2012